• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?

作者信息

Honore Patrick M, De Bels David, Kugener Luc, Redant Sebastien, Attou Rachid, Gallerani Andrea, Spapen Herbert D

机构信息

ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital, Place Van Gehuchtenplein, 4, 1020, Brussels, Belgium.

Medicine, Ageing & Pathology Research Group, Vrije Universiteit Brussel, Brussels, Belgium.

出版信息

Crit Care. 2019 Jan 17;23(1):15. doi: 10.1186/s13054-019-2311-2.

DOI:10.1186/s13054-019-2311-2
PMID:30654848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6337800/
Abstract
摘要

相似文献

1
Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?危重症肥胖患者的万古霉素药代动力学：临床医生能就此高枕无忧吗？
Crit Care. 2019 Jan 17;23(1):15. doi: 10.1186/s13054-019-2311-2.
2
Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.肥胖对危重症患者中抗菌药物药代动力学的影响：系统评价。
Int J Antimicrob Agents. 2016 Apr;47(4):259-68. doi: 10.1016/j.ijantimicag.2016.01.009. Epub 2016 Feb 23.
3
Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.肥胖与非肥胖外科重症监护病房患者每日静脉持续输注万古霉素的剂量需求
Crit Care. 2016 Jul 1;20(1):205. doi: 10.1186/s13054-016-1363-9.
4
The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.肾脏替代治疗方案中的变异性对危重症患者哌拉西林、美罗培南和万古霉素药物清除率的影响：文献分析和剂量方案*。
Crit Care Med. 2014 Jul;42(7):1640-50. doi: 10.1097/CCM.0000000000000317.
5
Pharmacokinetics of vancomycin in critically ill patients undergoing continuous venovenous haemodialysis.接受持续静静脉血液透析的危重症患者中万古霉素的药代动力学
Int J Antimicrob Agents. 2014 Oct;44(4):367-8. doi: 10.1016/j.ijantimicag.2014.06.002. Epub 2014 Jul 21.
6
Changes in vancomycin pharmacokinetics in critically ill infants.危重症婴儿万古霉素药代动力学的变化
Anaesth Intensive Care. 1995 Dec;23(6):678-82. doi: 10.1177/0310057X9502300603.
7
Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.机械通气对危重症患者连续输注万古霉素药代动力学的影响。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01249-17. Print 2017 Dec.
8
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.一种基于生理的药代动力学建模方法的开发，用于预测重症脓毒症患者中万古霉素的药代动力学
Clin Pharmacokinet. 2017 Jul;56(7):759-779. doi: 10.1007/s40262-016-0475-3.
9
Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.危重症患者接受长时间间断肾脏替代治疗时万古霉素的群体药代动力学。
Int J Antimicrob Agents. 2018 Aug;52(2):151-157. doi: 10.1016/j.ijantimicag.2018.03.001. Epub 2018 Mar 9.
10
Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population.对异质性重症患者群体中万古霉素药代动力学的前瞻性评估。
Diagn Microbiol Infect Dis. 2018 Dec;92(4):346-351. doi: 10.1016/j.diagmicrobio.2018.06.022. Epub 2018 Jun 30.

本文引用的文献

1
Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.肥胖与非肥胖外科重症监护病房患者每日静脉持续输注万古霉素的剂量需求
Crit Care. 2016 Jul 1;20(1):205. doi: 10.1186/s13054-016-1363-9.
2
New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.危重症患者万古霉素持续输注的新方案
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4750-6. doi: 10.1128/AAC.00330-16. Print 2016 Aug.
3
The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.万古霉素最低抑菌浓度在金黄色葡萄球菌感染中的临床意义：系统评价和荟萃分析。
Clin Infect Dis. 2012 Mar;54(6):755-71. doi: 10.1093/cid/cir935. Epub 2012 Feb 2.
4
Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus isolates: evaluation of the broth microdilution and Etest methods.耐甲氧西林凝固酶阴性葡萄球菌分离株的万古霉素 MIC：肉汤微量稀释法和 Etest 法的评估。
J Clin Microbiol. 2010 Dec;48(12):4652-4. doi: 10.1128/JCM.01182-10. Epub 2010 Sep 22.
5
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.万古霉素及其他抗菌药物在金黄色葡萄球菌下呼吸道感染患者中的药效学
Clin Pharmacokinet. 2004;43(13):925-42. doi: 10.2165/00003088-200443130-00005.